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Abstract
Background: Breast milk is an important source of staphylococci and other bacterial groups to
the infant gut. The objective of this work was to analyse the bacterial diversity in feces of breast-
fed infants and to compare it with that of formula-fed ones. A total of 23 women and their
respective infants (16 breast-fed and 7 formula-fed) participated in the study. The 16 women and
their infants provided a sample of breast milk and feces, respectively, at days 7, 14, and 35. The
samples were plated onto different culture media. Staphylococcal and enterococcal isolates were
submitted to genetic profiling and to a characterization scheme, including detection of potential
virulence traits and sensitivity to antibiotics.
Results: The feeding practice had a significant effect on bacterial counts. A total of 1,210 isolates
(489 from milk, 531 from breast-fed and 190 from formula-fed infants) were identified.
Staphylococcus epidermidis was the predominant species in milk and feces of breast-fed infants while
it was less prevalent in those of formula fed-infants. Enterococcus faecalis was the second
predominant bacterial species among the fecal samples provided by the breast-fed infants but it was
also present in all the samples from the formula-fed ones. The biofilm-related icaD gene and the
mecA gene were only detected in a low number of the S. epidermidis strains. Several enterococcal
isolates were also characterized and none of them contained the cylA or the vanABDEG antibiotic-
resistance genes. All were sensitive to vancomycin.
Conclusion: The presence of S. epidermidis is a differential trait of the fecal microbiota of breast-
fed infants. Globally, the staphyloccal isolates obtained from milk and feces of breast-fed infants
contain a low number of virulence determinants and are sensitive to most of the antibiotics tested.
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Background
Although the composition of the human intestinal micro-
biota is a major factor in the health status of both adults
and infants, the process of initial colonization of the neo-
natal gut and the origin of the first colonizers are aspects
that remain unclear.
Although the colonization pattern seems to be host-spe-
cific, this is generally accepted that, initially, the infant gut
would contain facultative anaerobes which would create a
reduced environment favourable to the establishment of
obligate anaerobes, such as Bacteroides, Clostridium and
Bifidobacterium species [1].
Traditionally, it has been widely accepted that the devel-
opment of the gut microbiota starts at birth and is greatly
influenced by the type of feeding [1-4]. The bacterial spec-
trum of breast-fed infants feces is narrower than that of
formula-fed ones although, in the formers, the counts of
fecal bifidobacteria and lactic acid bacteria are usually
notably higher than those found in formula-fed infants
[5,6]. Once weaning starts, differences between breast-fed
and formula-fed infants disappear rapidly and the gut eco-
system evolves into a stable host-specific community pre-
dominated by obligate anaerobes [1].
Human milk is a major factor in the initiation and devel-
opment of neonatal gut microbiota, not only because it
contains prebiotic substances that promote the growth of
selected bacterial groups in the infant gut [7], but also
because this substrate represents a continuous source of
microorganisms to the infant gut during several weeks
after birth [8,9]. The presence of a few predominant bac-
terial species in breast milk [10] may explain why gut
microbiota of breast-fed infants is composed of a narrow
spectrum of species, and a more diverse microbiota devel-
ops only after weaning.
However, few studies on the factors influencing the com-
position of the intestinal microbiota in early infancy have
had into account the influence of the bacteria naturally
present in human milk [11]. Staphylococci, and particu-
larly Staphylococcus epidermidis, seems to be the most pre-
dominant bacteria both in fresh and stored human milk
[9,10], but paradoxically they have received a marginal
attention regarding their role in the early colonization of
the infant gut. Additionally, the few studies that report the
detection of staphylococci in neonatal and infant feces are
controversial since their presence has been rated from low
[1] to high [12]. In this context, the objective of this study
was to compare the bacterial diversity of breast milk, feces
of breast-fed infants and feces of formula-fed ones by cul-
ture-based methods, with particular attention to those
species belonging to the Genus Staphylococcus. Addition-
ally, we investigated the role of breast milk as a source of
staphylococci to the infant gut and characterized the S.
epidermidis strains isolated from the feces of the breast-fed
infants. Finally, since enterococci seems to be another pre-
dominant bacterial group in the gut of both breast- and
formula-fed infants, the characterization of the enterococ-
cal strains isolated from infant feces constituted another
objective of this study.
Results
Bacterial counts in fecal and milk samples
Inoculation of suitable dilutions of the different fecal
samples (breast- or formula-fed 7-, 14-, or 35-day-old
infants) led to bacterial growth in all the culture media
tested. Globally, the values oscillated between 9.25 and
10.93 log10 CFU/g (Table 1). A two-way ANOVA, with
feeding practice and infant age as factors, revealed that the
feeding practice had a significant effect on bacterial counts
in infant feces (F-value = 10.11, P = 0.0045) but the influ-
ence of infant age was irrelevant. The mean bacterial
counts in the feces of breast-fed infants were almost 1
log10 CFU/g lower than the values corresponding to feces
of the formula-fed ones as revealed by Duncan's test
(Table 1). A second analysis with the culture medium
used for enumeration and the feeding practice as factors in
a two-way ANOVA showed important influence of the
culture media (F-value = 11.09, P < 0.0001) on the fecal
bacterial counts (Table 1). Aerobic bacterial counts (9.25
and 9.54 log10 CFU/g obtained in CNA and VRBA media,
respectively) were significantly lower than anaerobic bac-
terial counts (10.93 and 10.67 log10 CFU/g obtained in
WCh and MRS media, respectively). Mean bacterial
counts on BHI medium had intermediate values. Further-
more, in this second analysis, the interaction between the
culture medium employed and the feeding practice was
also significant (F-value = 3.32, P = 0.0141), suggesting a
differential influence of the feeding practice on the bacte-
rial groups present in infant feces (Table 1).
A more detailed comparison of the mean bacterial counts
in feces from breast-fed and formula-fed infants consider-
ing the results obtained in the different culture media for
each infant age revealed significant differences (P < 0.05)
in the bacterial counts corresponding to the culture media
that were incubated aerobically (BHI, VRBA and CNA) for
the samples obtained from 1- and 2-week old infants, but
not after 5 weeks (Table 2). In contrast, no significant dif-
ferences were observed on bacterial counts at any infant
age assayed in those media (WCh and MRS) that were
incubated anaerobically.
The average bacterial count in milk samples was 4.16 log10
CFU/ml when they were inoculated in BHI, CNA, WCh
and MRS media (Table 3). The CNA means decreased sig-
nificantly (P = 0.031, Student's t-test) from day 7 to 35
(from 4.22 to 3.69 log10 CFU/ml). In the rest of the media,BMC Microbiology 2008, 8:143 http://www.biomedcentral.com/1471-2180/8/143
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there were no statistically significant differences between
the mean bacterial counts through the period studied.
When the samples were inoculated in VRBA agar, no col-
onies could be isolated in 9, 8 and 6 milk samples at days
7, 14 and 35, respectively (Table 3). Globally, VRBA bac-
terial growth was not detected in any of the three samples
provided by 4 of the women that participated in the study.
The mean of the VRBA in the rest of the samples oscillated
between 4.42 and 4.80 log CFU/ml. A relationship (P <
0.070) could be observed between the bacterial counts
from breast milk and from infant feces in CNA (weeks 1,
2 and 5), MRS (week 1) and WCh (week 1).
Identification of the isolates
A total of 721 isolates were randomly selected from CNA,
BHI, MRS and WCh agar plates corresponding to feces of
the breast-fed (531 isolates) and formula-fed (190 iso-
lates) infants. Subsequently, they were identified by clas-
sical morphological and biochemical tests, species-
specific PCR and/or 16S rDNA sequencing.
S. epidermidis was the predominant species in feces of
breast-fed infants since it could be isolated from 86.05%
of the samples (Table 4). In this group, a slight decrease in
the number of S. epidermidis positive samples was
observed from day 7 (16/14) to day 35 (9/13). In contrast,
this species was only present in 13.33% of the samples
obtained from formula-fed infants. The difference in the
number of S. epidermidis-positive samples between breast-
and formula-fed infants was statistically significant (P <
0.0001). Presence of S. aureus and other Staphylococcus
species was similar in both groups.
Enterococcus faecalis was the second Gram-positive bacte-
rial species more widespread among the samples of the
breast-fed group (53.49%). However, since it was present
in 100% of the samples from the formula-fed one, there
was a significant difference between both groups regard-
ing this microorganism (P = 0.0011). Other enterococcal
species were also more widespread among feces of the for-
mula-fed infants but the differences were not statistically
different (Table 4). In contrast, streptococci could only be
isolated from feces of breast-fed infants. The percentage of
Table 1: Effects and interactions of feeding practice and infant age or culture media used for enumeration on bacterial counts in infant 
feces, as determined by repeated measures two-way ANOVA
Effect or interaction DF F value Pr > Fa Duncan's groupingb N Group Mean (log10 CFU g-1)
Feeding practice 1 10.11 0.0045 A 215 Breast-fed 9.87
B 105 Formula-fed 10.71
Infant age 2 0.18 0.8343 A 115 7-day old 10.16
A 105 14-day old 10.16
A 100 35-day old 10.12
Feeding practice × infant age 2 1.12 0.3360
Feeding practice 1 10.18 0.0044 A 215 Breast-fed 9.87
B 105 Formula-fed 10.71
Culture medium 4 11.09 < 0.0001 A 64 CNA 9.25
A 64 VRBA 9.54
B 64 BHI 10.34
BC 64 MRS 10.67
C 64 WCh 10.93
Feeding practice × culture medium 4 3.32 0.0141
aProbability value F test: significant when P < 0.05.
bDuncan's tests: groups within the same effect with the same letter do not differ significantly (P < 0.05).
N = 320
Table 2: Bacterial counts expressed as the mean log10 CFU g-1 
(SD) in feces of the breast-fed (n = 16) and formula-fed (n = 7) 
infants
Medium Week Breast-fed infants Formula-fed infants P-value*
BHI 1 9.93 (0.95) 11.42 (0.68) 0.0078
2 9.92 (0.51) 11.05 (0.39) 0.0001
5 10.06 (1.01) 10.83 (0.80) NS
VRBA 1 9.17 (1.07) 10.61 (1.09) 0.0415
2 9.24 (0.93) 10.62 (0.09) 0.0011
5 9.49 (1.35) 10.04 (0.70) NS
CNA 1 9.20 (0.91) 10.66 (0.73) 0.0143
2 9.08 (1.04) 10.46 (0.27) 0.0030
5 8.52 (1.05) 9.74 (0.84) NS
WCh 1 10.76 (0.91) 11.25 (0.97) NS
2 10.42 (0.99) 11.12 (0.20) NS
5 11.01 (0.55) 10.85 (0.51) NS
MRS 1 10.51 (0.98) 10.83 (1.04) NS
2 10.22 (1.03) 10.61 (0.27) NS
5 10.57 (0.59) 10.51 (0.52) NS
Statistical significance between the breast-fed group and the formula-
fed group (Student's t-test). NS, not significant difference.BMC Microbiology 2008, 8:143 http://www.biomedcentral.com/1471-2180/8/143
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samples containing other Gram-positive bacteria (includ-
ing bifidobacteria) and Gram-negative bacteria was also
significantly higher (P = 0.013 and 0.0008, respectively)
in samples from breast-fed infants (Table 4).
Globally, 140 isolates (26.36%) from the breast-fed group
were identified as S. epidermidis, 76 (14.31%) as Bifidobac-
terium sp. (B. adolescentis, B. brevis, B. infantis, B. bifidum,
B. longum, B. pseudocatenulatum, B. dentium, and B. angula-
tum) and 69 (12.99%) as E. faecalis (Table 5). Interest-
ingly, only 3 isolates (1.57%) from the formula-fed group
belonged to the S. epidermidis species while other 3 iso-
lates (1.57%) were identified as Bifidobacterium spp. In
contrast, 84 isolates (44.21%) of this group were E. faeca-
lis and this percentage increases to 52.63% when having
into account all the enterococcal species identified (Table
4). A considerable percentage (31–35%) of isolates from
both breast- and formula-fed infants was identified as
Gram-negative bacteria although they belonged to a wide
spectrum of species (Table 5).
All the milk samples contained S. epidermidis and, in gen-
eral, the percentage of samples in which staphylococci,
enterococci and streptococci were isolated was more sim-
ilar to that found among the feces of the breast-fed infants
than to that achieved by feces of the formula-fed group
(Table 5). A total of 489 breast milk isolates were ran-
domly isolated and 304 (62.16%) were identified as S.
epidermidis  (Table 5). The rest of the bacterial groups
found in feces of breast-fed infants were also detected in
breast milk (Table 5). Streptococci were isolated from
some samples of milk and feces of breast-fed infants but,
in contrast, they could not detected in feces of the for-
mula-fed ones (Table 5).
Genotyping of the S. epidermidis isolates by Random 
Amplification of Polymorphic DNA (RAPD)
The 444 S. epidermidis isolates from feces of breast-fed
infants and breast milk were genetically typified by the
RAPD technique and the analysis of the profiles revealed
the existence of 51 different genotypes. A representative of
each RAPD profile was selected for further characteriza-
tion. In addition, comparison of the RAPD profiles of
fecal S. epidermidis with those obtained from breast milk
isolates revealed that the same strain was shared by milk
Table 3: Bacterial counts expressed as the mean log10 CFU/g (SD) from breast milk of the mothers that participated in the study
Medium Week 1 (n = 16) Week 2 (n = 13) Week 5 (n = 14) Fa
BHI 4.63 (0.89) 4.58 (1.44) 4.22 (1.08) 0.72
VRBA NDb (n = 9) ND (n = 8) ND (n = 6) -
4.80 (1.35) (n = 7) 4.74 (1.21) (n = 5) 4.42 (0.91) (n = 8) -
CNA 4.22 (0.55) 4.03 (0.85) 3.69 (0.62) 2.97
WCh 4.22 (0.67) 4.43 (0.86) 4.27 (1.20) 1.41
MRS 3.97 (0.70) 3.79 (0.96) 4.14 (1.22) 0.21
aF2,10 value from a repeated measures ANOVA testing the effect of sampling occasion on bacterial counts of breast milk for each culture media used 
(p > 0.05)
bND, not detected
Table 4: Bacteria detected in the samples of breast milk and feces of the breast- and formula-fed infants and percentage of samples in 
which they were detected
Feces
Microorganism Milk Breast-fed infants Formula-fed infants P-valuea
Staphylococcus epidermidis 100.00% 86.05% 13.33% < 0.0001
Staphylococcus aureus 16.28% 16.28% 13.33% NSb
Other Staphylococcus spp. 16.28% 6.98% 6.67% NS
Enterococcus faecalis 20.93% 53.49% 100.00% 0.0011
Enterococcus faecium NDc 2.33% 13.33% NS
Other Enterococcus spp. 4.65% 9.30% 26.67% NS
Streptococcus spp. 27.91% 13.95% ND NS
Other Gram-positive bacteria 20.93% 69.77% 33.33% 0.0130
Gram-negative bacteria 46.51% 97.62% 66.67% 0.0008
a Statistical significance between the breast-fed group and the formula-fed group (χ2 test).
bNS, not significant (P > 0.05).
cND, not detected.BMC Microbiology 2008, 8:143 http://www.biomedcentral.com/1471-2180/8/143
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and infant feces in 12 of the 16 mother-infant pairs [see
additional file 1].
Characterization of the S. epidermidis strains
The 51 S. epidermidis strains were screened for the presence
of potential virulence traits [see additional file 1]. In rela-
tion to adhesin-encoding genes, a multiplex PCR assay
revealed the presence of the genes embp and atlE in all the
strains. In contrast the fbe gene could be detected in only
13 strains (25%). The biofilm-related icaD  gene was
detected in 11 strains (20%) and, in general, there was a
good correlation between the presence of such gene and
the results obtained using the CRA assay, which deter-
mines potential for biofilm production. Hemolytic activ-
ity could not be detected among the assayed strains.
Among the 17 strains showing oxacillin resistance, the
mecA gene could be detected by PCR in 9 (53%). In con-
trast, mecA amplification was obtained from 6 oxacillin-
sensitive strain. Only 3 strains showed the simultaneous
presence of mecA and icaD [see additional file 1]. The type
of SCC mec was determined in all the mecA+ strains. The
ccrB gene could be amplified from all the mecA+ strains
and, on the basis of the ccrB restriction pattern with HinfI
(type IV: 264, 227 and 154 pb; type III: 537 and 106 bp)
or with HinfI/BsmI (type IV: 227, 171, 153 and 93 bp; type
III: 320, 174, 106 and 44 bp), all were assigned to type IV,
which is generally carried by community-acquired staphy-
lococci.
The determination of the MIC's of 21 antibiotics or anti-
biotics mixtures for the 51 S. epidermidis strains revealed
that all of them were sensitive to the lower concentration
of nitrofurantoin (32 μg/ml), vancomycin (≤ 2 μg/ml;
with one exception) and rifampin (1 μg/ml; with two
exceptions), while the results against the rest of antibiotics
were variable depending on the strain [see additional file
2]. Independently of their origin, most of the strains were
sensitive to quinupristin/dalfopriscin (≤ 0.25 μg/ml), tri-
methoprim/sulfamethoxazole (MIC < 2/38 μg/ml), gen-
tamicyn (≤ 2 μg/ml), linezolid (≤ 2 μg/ml), fosfomycin (≤
16 μg/ml), ciprofloxacin (≤ 0.5 μg/ml), chloramphenicol
(≤ 16 μg/ml), ampicillin (≤ 4 μg/ml) and teicoplanin (≤ 1
μg/ml). The percentage of susceptible strains was lower
for imipenem (≤ 0.12 μg/ml), penicillin (≤ 4 μg/ml), and
tetracycline (≤ 8 μg/ml).
Characterization of the Enterococcus faecium and 
Enterococcus faecalis strains
None of the 4 E. faecium strains tested have the presence
of any virulence determinant (ccf,  cpd,  cad,  cob,  efaAfs,
efaAfm, agg2, gelE,cylA, epsfs) while all the E. faecalis isolates
tested possessed some potential virulence determinants
[see additional file 3]. All the sex pheromone determi-
nants were detected in 19 E. faecalis strains but the gene
Table 5: Identification of the colonies isolated from breast milk and feces from breast- and formula-fed infants
Milk Breast-fed infants Formula-fed infants
Microorganisms N° colonies (%) N° colonies (%) N° colonies (%)
1. Gram-positive bacteria:
Staphylococcus epidermidis 304 (62.16) 140 (26.36) 3 (1.57)
Other staphylococci 24 (4.91) 21 (3.95) 3 (1.57)
Enterococcus faecalis 21 (4.29) 69 (12.99) 84 (44.21)
Other enterococci 1 (0.20) 6 (1.12) 16 (8.42)
Streptococcus spp. 35 (7.15) 17 (3.20) NDa
Bifidobacterium spp. 4 (0.81) 74 (13.93) 3 (1.58)
Lactobacillus spp. 2 (0.40) 6 (1.13) 15 (7.89)
Other Gram-positive bacteriab 22 (4.49) 31 (5.83) ND
2. Gram-negative bacteria:
Acinetobacter johnsonii 5 (1.03) ND ND
Bacteroides spp. ND 6 (1.13) 2 (1.05)
Burkholderia spp. 2 (0.40) 5 (0.95) ND
Citrobacter spp. 7 (1.44) 4 (0.75) 5 (2.63)
Escherichia coli 37 (7.56) 94 (17.70) 50 (26.32)
Klebsiella spp. 7 (1.44) 23 (4.33) 3 (1.58)
Pantoea agglomerans ND ND 2 (1.05)
Enterobacter spp. 7 (1.44) 30 (5.64) 4 (2.10)
Other Gram-negative bacteriac 11 (2.25) 5 (0.95) ND
Total number of colonies identified 489 531 190
aND, not detected; bOther Gram-positive bacteria: Actinomyces spp., Kocuria spp., Propionibacterium spp.; cOther Gram-negative bacteria: Kluyvera 
cryocescens, Pseudomonas spp., Shigella spp.BMC Microbiology 2008, 8:143 http://www.biomedcentral.com/1471-2180/8/143
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encoding cytolysin (cylA) couls only be detected in 7
strains. The results for the rest of the enterococcal genes
were variable depending on the strains [see additional file
3].
All the E. faecium and E. faecalis strains were susceptible to
low concentrations of penicillin, ampicillin, cipro-
floxacin, fosfomycin, nitrofurantoine, tetraciclyne, eryth-
romycin, vancomycin, teicoplanin, chloramphenicol and
rifampicin [see additional file 4]. The percentage of strains
resistant to quinupristin/dalfopriscin (MIC ≥ 4 μg/ml)
was 79.31% while 34.48% of them showed resistance to
streptomycin (MIC > 1000 μg/ml). Only one strain was
resistant to gentamycin (MIC > 500 μg/ml) and only
another one to linezolid (MIC ≥ 8 μg/ml) [see additional
file 4].
Discussion
Colostrum and milk play key roles in the initiation, devel-
opment and composition of the infant gut microbiota
since they contain a variety of factors, such as inmu-
noglobulins, inmunocompetent cells, fatty acids,
polyamines, oligosaccharides, lysozyme, lactoferrin, and
antimicrobial peptides, that modulate bacterial growth in
the intestinal ecosystem. In addition, breast milk is an
important and continuous source of commensal bacteria,
including staphylococci, streptococci, and lactic acid bac-
teria, to the infant gut [8-10]. Therefore, it is not strange
that the bacterial composition of the faecal flora of the
breast-fed infant reflects the bacterial composition of
breast milk [9].
In this work, S. epidermidis was the predominant species in
milk of the lactating women and in the feces of their
respective infants while it was almost absent in samples
from feces of formula-fed infants. Previously, different
studies have reported that this bacterial species is the pre-
dominant one in human milk from healthy women
[9,10]. In contrast, E. faecalis was the dominant species
among the isolates obtained from feces of formula-fed
infants. Similarly, a molecular analysis revealed that E.
faecalis was present in feces of a formula-fed infant on the
sixth day of life but, in contrast, S. epidermidis could not be
detected [13]. It has been suggested that the major differ-
ences between the microbiological composition of
human milk and infant formula are probably the main
factor responsible for the differences observed between
the gut microbiota of breast- and formula-fed infants [1-
4,14]. Other bacterial groups, such as lactobacilli were less
prevalent and this fact may be due to their lower presence
or to the fact that their isolation is difficult with the cul-
ture media used in this study.
Interestingly, the same S. epidermidis strain (as determined
by genetic profiling) was isolated from milk and feces of
several each mother-infant pairs. In the last years, it has
been shown that breast milk plays an important role in
the vertical mother-to-child transmission of lactic acid
bacteria [5,8,15,16]. In this context, our results indicate
that an abundant presence of S. epidermidis in the infant
gut is a differential feature of the feces of breast-fed infants
when compared to those of formula-fed infants.
Studies carried 20 years ago already described that staphy-
lococci were common in feces of breast-fed infants
[12,17,18]. More recently, it has been shown that coagu-
lase-negative staphylococci colonized 100% of breast-fed
Western infants from day 3 onwards [19]. Such staphylo-
cocci colonized vaginally and cesarean section-delivered
infants equally early. Some authors suggest that, in fact,
staphylococcal colonization of the infant gut has
increased from the 70s to the present [19,20]. It has been
speculated that this may be an effect of a highly hygienic
lifestyle which leads to a delayed acquisition of "tradi-
tional" fecal bacteria, such as enterobacteria [19]. In their
absence, staphylococci become the first gut colonizers and
the results of our work suggest that breast milk could be
the main source. Then, the population decreased signifi-
cantly from 4 week until 6 month of age. Similarly, in our
study the number of samples from breast-fed infants in
which  S. epidermidis could be isolated decreased from
week 1 to week 5.
The different S. epidermidis strains isolated from feces of
the breast-fed infants were submitted to a characterization
scheme that included the detection of virulence-associ-
ated determinants and the profile of antibiotic resistances
in order to confirm the prevalence of non-pathogenic iso-
lates in the healthy infant gut. Among the S. epidermidis
strains analyzed, the presence of adhesion-related genes
was very high, independently of the sample from which
they were isolated. All of them carried the embp and atlE
genes and 25% of the strains harbored the fbe gene. The
cell surface proteins may help to explain the high preva-
lence of S. epidermidis in breast milk since they could con-
tribute to the bacterial attachment to the mammary areola
and ducts throughout the lactation period. In contrast, the
percentage of strains carrying the biofilm-related ica
operon was much lower (20%). A potential relationship
between S. epidermidis infection and the presence of such
operon has been reported [21]. In fact, biofilm formation
has been described in many cases of staphylococcal mas-
titis and this is the reason why such property is considered
as a potential virulence factor [22]. A few strains showed
methicillin resistance but methicillin-resistant staphylo-
cocci are being reported with increasing frequency in the
community and they are commonly isolated from healthy
hosts [23]. Globally, most of the S. epidermidis strains
characterized in this study harbour several adhesion fac-
tors but not antibiotic resistance or virulence determi-BMC Microbiology 2008, 8:143 http://www.biomedcentral.com/1471-2180/8/143
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nants. Since staphylococcal strains provided first by
colostrum and, later, by breast milk may successfully com-
pete with potentially pathogenic strains found in the hos-
pital environment, their application as probiotics in
neonatal units could be considered in the future if works
in progress (including complete genome sequencing and
analysis) confirm the safety of selected strains.
Enterococci, and particularly E. faecium and E. faecalis,
become normal components of the human gastro-intesti-
nal soon after birth. On the other hand, enterococci are
opportunistic pathogens that may cause nosocomial
infections in neonates suffering underlying diseases [24].
However, the presence of virulence determinants and the
antibiotic resistance pattern appears to be strain-specific
among isolates studied so far [25,26]. In fact, it seems that
human isolates involved in clinical infection fell into a
well defined subgroup, which suggest that there may be a
genetic basis for strains associated with human disease
[27,28]. In addition, enterococci not involved in human
clinical infection are generally sensitive to clinically rele-
vant antibiotics, including vancomycin [24,26], as hap-
pened with the enterococcal strains analyzed in this work.
Conclusion
Our results indicate that the feeding practice (breast- or
formula fedding) had a significant effect on bacterial
counts and fecal microbiota composition. S. epidermidis is
the most prevalent species in feces of breast-fed infants
while it is practically absent in those of formula fed-
infants. Therefore, S. epidermidis can be considered as a
differential trait of the fecal microbiota of breast-fed
infants although this finding requires further confirma-
tion in larger studies. The staphyloccal isolates only con-
tain a low number of virulence determinants and are
sensitive to most of the antibiotics tested. Additionally,
we have observed that E. faecalis is the second bacterial
species in feces of the breast-fed group but it is also
present in all the samples from the formula-fed one. The
characterization of several representative enterococcal iso-
lates revealed that none of them were resistant to vanco-
mycin. Streptococci were isolated from some samples of
milk and feces of breast-fed infants but, in contrast, they
could not detected in feces of the formula-fed ones.
Methods
Subjects and sampling
A total of 23 women and their respective infants partici-
pated in the study and they were enrolled according with
the following criteria: (a) healthy women without present
or past underlying conditions; (b) normal full-term preg-
nancy; (c) vaginal delivery; and (d) absence of infant and/
or maternal perinatal problems, including mastitis.
Among the 23 women, 16 breast-fed their infants while
the remaining 7 voluntarily choose a commercial formula
devoid of prebiotics to fed their infants despite they were
advised of the benefits of breastfeeding. The assessment of
sample size for both groups of infants (breast-fed and for-
mula-fed) was based on an estimated large effect size of
the feeding practice on the infant gut microbiota (0.8 log
units of diference in the mean values of bacterial counts),
with an α at 0.05 and a statistical power of 83% in a vari-
ance analysis of repeated measures. All volunteers gave
written informed consent to the protocol, which was
approved by the Ethical Committee of Hospital Joan XXIII
(Tarragona, Spain). The participants provided a sample of
breast milk (breastfeeding group) and infant feces at days
7, 14, and 35 after birth. All the samples were collected in
sterile tubes as previously described [10] and kept at 4°C
until delivery to the laboratory.
Isolation and enumeration of bacteria
Proper peptone water dilutions of the milk and feces sam-
ples were plated in triplicate onto Brain Heart Infusion
(BHI, Oxoid, Basingstoke, UK; a general-purpose medium
suitable for the cultivation of non-fastidious bacteria,
yeasts and moulds), Violet Red Bile Agar (VRBA; Difco,
Detroit, MI; a selective medium for the isolation of entero-
bacteria) and Columbia Nadilixic Acid Agar (CNA,
BioMerieux; a highly nutritious, general-purpose medium
for the isolation and cultivation of fastidious microorgan-
isms) agar plates, which were aerobically incubated at
37°C for 24 h. Parallel, the same samples were also cul-
tured on Wilkins-Chalgren (WCh, Oxoid; a general
medium for isolating anaerobic bacteria) and de Man,
Rogosa, and Sharpe (MRS, Oxoid; a medium for the isola-
tion of lactic acid bacteria and bifidobacteria) agar plates,
which were incubated anaerobically (85% nitrogen, 10%
hydrogen, 5% carbon dioxide) in an anaerobic worksta-
tion (MINI-MACS, DW Scientific, Shipley, UK) at 37°C
for 48 h. Between 5–10 isolates from each culture
medium where growth was observed (~35 isolates per
sample and week) were randomly selected, grown in BHI
broth and stored at -80°C in the presence of glycerol
(30%, v/v).
Identification of the bacterial isolates
The selected isolates were observed by optical microscopy
to determine their morphology and Gram staining. Addi-
tionally, they were tested for catalase, oxidase and coagu-
lase activities and for grow on plates of Baird-Parker (BP,
BioMerieux) and Kanamycin Aesculin Azide Agar (KAA,
Oxoid). All the isolates corresponding to samples (milk/
feces) obtained at weeks 1, 2 and 5 were identified to the
species level. Initially, most of the isolates that, on the
basis of such preliminary tests, seemed to belong to the
genus Staphylococcus were identified as S. epidermidis, S.
aureus or S. hominis by a novel multiplex PCR method
based on the dnaJ genes. Briefly, a single colony growing
on solid media was removed with a sterile plastic tip andBMC Microbiology 2008, 8:143 http://www.biomedcentral.com/1471-2180/8/143
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resuspended in 100 μl of sterile deionized water in a
microcentrifuge tube. Then 100 μl of chloroform/isoamyl
alcohol (24:1) was added to the suspensions, and after
vortexing for 5 s the mixture was centrifuged at 16,000 × g
for 5 min at 4°C. Then 5–10 μl of the upper aqueous
phase was used as a source of DNA template for PCR with
primers J-StGen (5'-TGGCCAAAAGAGACTATTATGA-3'),
J-StAur (5'-GGATCTCTTTGTCTGCCG-3'), J-StEpi (5'-
CCACCAAAGCCTTGACTT-3') and J-StHom (5'-TTGAC-
CACTACCCTCACAC-3') in a Icycler thermocycler (Bio-
Rad Laboratories, Richmond, CA). The primer pairs J-
StGen/J-StAur, J-StGen/J-StEpi and J-StGen/J-StHom
result in a 337 bp S. aureus species-specific fragment, 249
bp S. epidermidis species-specific fragment and a 589 bp S.
hominis species-specific fragment, respectively. PCR condi-
cions were as follows: 1 cycle of 94°C for 4 min, 30 cycles
of 94°C for 30 sec, 60°C for 30 sec, and 72°C for 30 sec,
and a final extension of 72°C for 5 min. On the other
hand, most of the isolates that seemed to belong to the
genus Enterococcus could be identified by PCR species-spe-
cific detection of enterococcal ddl genes, which encode D-
alanine:D-alanine ligases, following the protocol
described by Dutka-Malen et al. [29]. Confirmation of sta-
phylococci and enterococci identification and identifica-
tion of the rest of the isolates was performed by PCR
sequencing of a 470 pb fragment of the 16S rRNA gene as
described by Kullen et al. [30]. The amplicons were puri-
fied using the Nucleospin® Extract II kit (Macherey-Nagel,
Düren, Germany) and sequenced at the Genomics Unit of
the Universidad Complutense de Madrid, Spain. The
resulting sequences were used to search sequences depos-
ited in the EMBL database using BLAST algorithm and the
identity of the isolates was determined on the basis of the
highest scores (> 98%).
Genotyping of the S. epidermidis, E. faecium and E. 
faecalis isolates by Random Amplification of Polymorphic 
DNA (RAPD)
The S. epidermidis, E. faecium and E. faecalis isolates were
typified by RAPD. DNA was extracted from isolated colo-
nies following the protocol of Ruiz-Barba et al. [31] and
was used as a template to determine the RAPD profile
with the primer OPL5 (5'-ACGCAGGCAC-3'') [32]. This
technique was also used to compare S. epidermidis isolates
obtained from breast milk and infant feces of the different
mother-infant pairs in order to know if there may be a ver-
tical mother-to-child transmission of this species.
Screening for potential virulence determinants, mecA, 
SSCmec and antibiotic susceptibility among the S. 
epidermidis isolates
Based on their different RAPD, 51 S. epidermidis strains
were selected for further studies. Presence of genes embp,
fbe and atlE (which products are involved in adhesion)
and icaD (involved in biofilm formation), was evaluated
using primers couples described previously [33-36]. In the
case of fbe, atlE and icaD, a novel multiplex PCR format
was designed using the following conditions: 5 min at
94°C followed by 30 cycles of 94°C for 1 min, 60°C for
30 s, 72°C for 1 min and, then, a final extension of 5 min
at 72°C. On the other hand, conditions for amplification
of the embp gene were as follows: 5 min at 94°C for 1 cycle
followed by 30 cycles of 30 s at 94°C, 1 min at 58°C, 1
min at 72°C, and a final extension step at 72°C for 5 min.
The hemolytic activity of the isolates was determined on
Columbia agar supplemented with 5% horse blood
(COH, BioMerieux). After an incubation of 72 h at 37°C,
the plates were analyzed and the isolates were classified as
non hemolytic (no halo), moderately hemolytic (halo <
1.5 mm) or strongly hemolytic (halo > 1.5 mm). The abil-
ity of the S. epidermidis isolates to form biofilms was
assessed using the Congo Red agar assay (CRA) [37]. Pres-
ence of the mecA gene, conferring methicillin-resistance,
was evaluated in S. epidermidis isolates following the pro-
tocol described in a previous study [38]. The mecA gene is
located in a mobile element in the staphylococcal chro-
mosome, constituting the cassette SCC mec. The SCC mec
element was submitted to a typing procedure previously
described [39], which is based on the PCR amplification
of the ccrB gene followed by a restriction fragment length
polymorphism (RFLP) analysis using endonucleases HinfI
and BsmI.
The determination of the MICs to several antibiotics was
evaluated by a microdilution method using the Sensititre
plates Staenc1F (Trek Diagnostic Systems, Cleveland, OH)
following the manufacturer's instructions. The antibiotics
analyzed were: penicillin, ampicillin, amoxycillin-clavu-
lanic acid, teicoplanin, chloramphenicol, erythromycin,
mupirocin, streptomycin, gentamicin, clindamycin, oxa-
cillin, ciprofloxacin, fosfomycin, imipenem, nitrofuranto-
ine, trimethoprim-sufamethoxazole, tetracycline,
vancomycin, linezolid, quinupristin-dalfopriscin and
rifampin.
Screening for potential virulence determinants, van genes 
and antibiotic susceptibility among the enterococcal 
isolates
Similarly, 25 E. faecalis and 4 E. faecium strains (one rep-
resentative of each of the RAPD group found in this study)
were further characterized. A novel multiplex PCR
method was used to detect the presence of virulence deter-
minants encoding sex pheromones (ccf,  cpd,  cad,  cob),
adhesins (efaAfs, efaAfm) and products involved in aggrega-
tion (agg2), biosynthesis of an extracellular metalloen-
dopeptidase (gelE), biosynthesis of cytolysin (cylA) and
immune evasion (epsfs). The primers couples and PCR
conditions used to detect all the genes cited above were
those proposed by Eaton and Gasson [25]. Control strains
used in PCR experiments were E. faecalis strains F4 (efaAfs
+BMC Microbiology 2008, 8:143 http://www.biomedcentral.com/1471-2180/8/143
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gelE+ agg+ cylMBA+ esp+ cpd+ cob+ ccf+ cad+), P36 (efaAfs
+ gelE+
agg+ cylA+ esp+ cpd+ cob+ ccf+ cad+) and P4 (efaAfs
+ gelE+ agg+
cylA+ cpd+ cob+ ccf+ cad+), and E. faecium P61 (efaAfm
+ esp+)
[25]. The hemolytic activity of the isolates and their ability
to form biofilms were assessed exactly as described for the
staphylococcal isolates.
PCR reactions for vanA and vanB genes were prepared as
described Dutka-Malen et al. [29] and Ramos-Trujillo et
al. [40], respectively. E. faecium BM4147 (resistant to van-
comycin, VanA+) and E. faecalis V583 (resistant to vanco-
mycin, VanB+) were used as positive controls. Detection of
vanD, vanE and vanG genes in the E. faecalis isolates was
performed as previously described [41-43]. The determi-
nation of the MICs to several antibiotics was evaluated by
the microdilution method cited for the staphylococcal
isolates.
Statistical analysis
Microbiological data, recorded as colony forming units
(CFU) per gram of feces, or milliliter of milk, were trans-
formed to logarithmic values before statistical analysis.
The reported values of bacterial counts are the mean val-
ues of duplicate or triplicate determinations and the
standard deviation (SD) of the mean. Bacterial counts in
feces samples were analyzed by two-way ANOVA for
repeated measures using the General Lineal Model proce-
dure to determine the effect of feeding practice (breast
feeding and formula feeding) and infant age (days 7, 14,
and 35 after birth) or culture media used for enumeration
of bacterial counts (BHI, VRBA, CNA, WCh, and MRS)
and their interaction. The two-way ANOVA was followed
by Duncan's multiple range tests (α = 0.05). A one-way
repeated measures ANOVA was used to test for differences
amongst the means of bacterial counts from breast milk
for each culture media used with sampling occasion as
repeated measures variable. The statistical software pack-
age SAS version 9.1 (SAS Institute Inc., Cary, NC, USA)
was used for these analysis.
Student's t-tests were applied to determine statistically sig-
nificant differences between the bacterial counts in feces
of breast-fed and formula-fed infants at each infant age
and for each culture media used for enumeration of bac-
terial counts. Comparison of bacterial counts in breast
milk obtained at different sampling times (1, 2, and 5
weeks) was made also using Student's t-tests. Two-sided
probability (P) values ≥ 0.05 were considered non signifi-
cant. Identified bacterial isolates from infant feces were
analyzed to evaluate the association between the presence
of a specific kind of bacteria in the fecal samples and the
feeding practice using a χ2 tests and a significance level of
P < 0.05.
The Pearson's product-moment correlation was used to
assess the association between bacterial counts in breast
milk and in infant feces for each medium and sampling
time. Student's t-tests, χ2 tests and Pearson's test were car-
ried out with the Statgraphics Plus 5.0 software (Manugis-
tics, Inc., Rockville, Md.).
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